Latest Organofluorides Stories
The Firm is looking forward to a status conference on March 19, 2015 that will discuss issues that affect hundreds of Risperdal lawsuit claimants. New York,
DUBLIN, March 9, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that it has launched a generic version of Fougera's Temovate(®)
The Firm is representing numerous plaintiffs who have filed Risperdal lawsuits in Pennsylvania that allege the antipsychotic medication caused gynecomastia, or male breast development.
The Firm is representing numerous clients in Risperdal lawsuits that have been filed in the Pennsylvania mass tort proceeding, all of whom allegedly developed gynecomastia due to treatment with
NORWALK, Conn., March 5, 2015 /PRNewswire/ -- UBM Medica US announces that OncoTherapy Network,
BAUDETTE, Minn., March 5, 2015 /PRNewswire/ -- ANI Pharmaceuticals, Inc.
The Firm is representing a number of Lipitor lawsuit plaintiffs in federal court, all of whom allegedly developed Type 2 diabetes due to their use of the statin medication. New
BRISTOL, Tenn., March 4, 2015 /PRNewswire/ -- UPM Pharmaceuticals, a division of Gregory Pharmaceutical Holdings, Inc., has reached an agreement with Sprout Pharmaceuticals to manufacture Flibanserin
The Firm is currently representing numerous Risperdal lawsuit plaintiffs who raise similar questions regarding the tactics used to drive sales of the atypical antipsychotic medication.
Researchers at MIT have developed a new device which uses nanoparticles to block the genes that confers drug resistance, offering a new way to prevent chemotherapy and other treatments from losing their effectiveness in treating cancer over time.
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.